Min et al.25 reported that thioridazine inhibited Mcl-1 and c-FLIP expression in a ROS-dependent manner, resulting in induction of apoptosis in TRAIL-treated human renal carcinoma Caki cells. Here, MCL1 is linked to renal carcinoma.